Lingolol

Gregory MSIlluminating New Paths in the Treatment of Multiple Sclerosis Relapses - Early and Specialized Rehabilitation<a href="https://clinicaltrials.gov/study/NCT06956326?cond=Multiple+Sclerosis" rel="nofollow noopener noreferrer" translate="no" target="_blank">https://clinicaltrials.gov/study/NCT06956326?cond=Multiple+Sclerosis</a><a href="https://med-mastodon.com/tags/MSchat" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#MSchat</a> <a href="https://med-mastodon.com/tags/Neurology" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#Neurology</a> <a href="https://med-mastodon.com/tags/MultipleSclerosis" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#MultipleSclerosis</a> <a href="https://med-mastodon.com/tags/ClinicalTrial" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#ClinicalTrial</a> <a href="https://med-mastodon.com/tags/botsFightMS" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#botsFightMS</a>

Gregory MSVista Protein Expression of Monocyte and T Cell Subsets in Multiple Sclerosis and Its Clinical Correlation<a href="https://clinicaltrials.gov/study/NCT06957145?cond=Multiple+Sclerosis" rel="nofollow noopener noreferrer" translate="no" target="_blank">https://clinicaltrials.gov/study/NCT06957145?cond=Multiple+Sclerosis</a><a href="https://med-mastodon.com/tags/MSchat" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#MSchat</a> <a href="https://med-mastodon.com/tags/Neurology" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#Neurology</a> <a href="https://med-mastodon.com/tags/MultipleSclerosis" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#MultipleSclerosis</a> <a href="https://med-mastodon.com/tags/ClinicalTrial" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#ClinicalTrial</a> <a href="https://med-mastodon.com/tags/botsFightMS" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#botsFightMS</a>

Gregory MSExamining the Effect of Mandala Art Therapy on Symptoms and Quality of Life in Multiple Sclerosis Patients<a href="https://clinicaltrials.gov/study/NCT06955962?cond=Multiple+Sclerosis" rel="nofollow noopener noreferrer" translate="no" target="_blank">https://clinicaltrials.gov/study/NCT06955962?cond=Multiple+Sclerosis</a><a href="https://med-mastodon.com/tags/MSchat" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#MSchat</a> <a href="https://med-mastodon.com/tags/Neurology" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#Neurology</a> <a href="https://med-mastodon.com/tags/MultipleSclerosis" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#MultipleSclerosis</a> <a href="https://med-mastodon.com/tags/ClinicalTrial" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#ClinicalTrial</a> <a href="https://med-mastodon.com/tags/botsFightMS" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#botsFightMS</a>

Gregory MSEarly Identification of Brain Lesions in Multiple Sclerosis With Phase Sensitive Inversion Recovery MRI: A Cross-sectional Study<a href="https://clinicaltrials.gov/study/NCT06955832?cond=Multiple+Sclerosis" rel="nofollow noopener noreferrer" translate="no" target="_blank">https://clinicaltrials.gov/study/NCT06955832?cond=Multiple+Sclerosis</a><a href="https://med-mastodon.com/tags/MSchat" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#MSchat</a> <a href="https://med-mastodon.com/tags/Neurology" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#Neurology</a> <a href="https://med-mastodon.com/tags/MultipleSclerosis" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#MultipleSclerosis</a> <a href="https://med-mastodon.com/tags/ClinicalTrial" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#ClinicalTrial</a> <a href="https://med-mastodon.com/tags/botsFightMS" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#botsFightMS</a>

Gregory MSSafety and Tolerability of TOP-N53 Applied on Digital Ulcers in Patients With Systemic Sclerosis<a href="https://clinicaltrials.gov/study/NCT06954597?cond=Multiple+Sclerosis" rel="nofollow noopener noreferrer" translate="no" target="_blank">https://clinicaltrials.gov/study/NCT06954597?cond=Multiple+Sclerosis</a><a href="https://med-mastodon.com/tags/MSchat" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#MSchat</a> <a href="https://med-mastodon.com/tags/Neurology" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#Neurology</a> <a href="https://med-mastodon.com/tags/MultipleSclerosis" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#MultipleSclerosis</a> <a href="https://med-mastodon.com/tags/ClinicalTrial" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#ClinicalTrial</a> <a href="https://med-mastodon.com/tags/botsFightMS" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#botsFightMS</a>

Gregory MSTenofovir Alafenamide Fumarate and Epstein-Barr virus activity in people with MS – The TAF-MS study<a href="https://euclinicaltrials.eu/search-for-clinical-trials/?lang=en&EUCT=2023-503814-62-00" rel="nofollow noopener noreferrer" translate="no" target="_blank">https://euclinicaltrials.eu/search-for-clinical-trials/?lang=en&EUCT=2023-503814-62-00</a><a href="https://med-mastodon.com/tags/MSchat" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#MSchat</a> <a href="https://med-mastodon.com/tags/Neurology" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#Neurology</a> <a href="https://med-mastodon.com/tags/MultipleSclerosis" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#MultipleSclerosis</a> <a href="https://med-mastodon.com/tags/ClinicalTrial" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#ClinicalTrial</a> <a href="https://med-mastodon.com/tags/botsFightMS" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#botsFightMS</a>

Gregory MSHOBSCOTCH-MS-Efficacy Trial<a href="https://clinicaltrials.gov/study/NCT06951919?cond=Multiple+Sclerosis" rel="nofollow noopener noreferrer" translate="no" target="_blank">https://clinicaltrials.gov/study/NCT06951919?cond=Multiple+Sclerosis</a><a href="https://med-mastodon.com/tags/MSchat" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#MSchat</a> <a href="https://med-mastodon.com/tags/Neurology" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#Neurology</a> <a href="https://med-mastodon.com/tags/MultipleSclerosis" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#MultipleSclerosis</a> <a href="https://med-mastodon.com/tags/ClinicalTrial" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#ClinicalTrial</a> <a href="https://med-mastodon.com/tags/botsFightMS" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#botsFightMS</a>

Gregory MSEffect of Dual-Task Training and Cognitive Rehabilitation in Individuals With Multiple Sclerosis.<a href="https://clinicaltrials.gov/study/NCT06949696?cond=Multiple+Sclerosis" rel="nofollow noopener noreferrer" translate="no" target="_blank">https://clinicaltrials.gov/study/NCT06949696?cond=Multiple+Sclerosis</a><a href="https://med-mastodon.com/tags/MSchat" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#MSchat</a> <a href="https://med-mastodon.com/tags/Neurology" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#Neurology</a> <a href="https://med-mastodon.com/tags/MultipleSclerosis" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#MultipleSclerosis</a> <a href="https://med-mastodon.com/tags/ClinicalTrial" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#ClinicalTrial</a> <a href="https://med-mastodon.com/tags/botsFightMS" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#botsFightMS</a>

Gregory MSUpper Limb Function in Mental Health Disorders<a href="https://clinicaltrials.gov/study/NCT06949449?cond=Multiple+Sclerosis" rel="nofollow noopener noreferrer" translate="no" target="_blank">https://clinicaltrials.gov/study/NCT06949449?cond=Multiple+Sclerosis</a><a href="https://med-mastodon.com/tags/MSchat" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#MSchat</a> <a href="https://med-mastodon.com/tags/Neurology" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#Neurology</a> <a href="https://med-mastodon.com/tags/MultipleSclerosis" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#MultipleSclerosis</a> <a href="https://med-mastodon.com/tags/ClinicalTrial" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#ClinicalTrial</a> <a href="https://med-mastodon.com/tags/botsFightMS" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#botsFightMS</a>

Gregory MSAdministration of Fingolimod in Greek Patients With Multiple Sclerosis.<a href="https://clinicaltrials.gov/study/NCT06949956?cond=Multiple+Sclerosis" rel="nofollow noopener noreferrer" translate="no" target="_blank">https://clinicaltrials.gov/study/NCT06949956?cond=Multiple+Sclerosis</a><a href="https://med-mastodon.com/tags/MSchat" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#MSchat</a> <a href="https://med-mastodon.com/tags/Neurology" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#Neurology</a> <a href="https://med-mastodon.com/tags/MultipleSclerosis" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#MultipleSclerosis</a> <a href="https://med-mastodon.com/tags/ClinicalTrial" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#ClinicalTrial</a> <a href="https://med-mastodon.com/tags/botsFightMS" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#botsFightMS</a>

Gregory MSDESIRE MS: A prospective randomized non-inferiority trial comparing anti-CD20 maintenance versus De-Escalation Strategy In Relapsing-Remitting Multiple Sclerosis<a href="https://euclinicaltrials.eu/search-for-clinical-trials/?lang=en&EUCT=2024-513292-40-00" rel="nofollow noopener noreferrer" translate="no" target="_blank">https://euclinicaltrials.eu/search-for-clinical-trials/?lang=en&EUCT=2024-513292-40-00</a><a href="https://med-mastodon.com/tags/MSchat" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#MSchat</a> <a href="https://med-mastodon.com/tags/Neurology" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#Neurology</a> <a href="https://med-mastodon.com/tags/MultipleSclerosis" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#MultipleSclerosis</a> <a href="https://med-mastodon.com/tags/ClinicalTrial" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#ClinicalTrial</a> <a href="https://med-mastodon.com/tags/botsFightMS" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#botsFightMS</a>

Gregory MSLaughter Yoga for Improving Sexual Function and Psychosocial Outcomes in Multiple Sclerosis<a href="https://clinicaltrials.gov/study/NCT06947434?cond=Multiple+Sclerosis" rel="nofollow noopener noreferrer" translate="no" target="_blank">https://clinicaltrials.gov/study/NCT06947434?cond=Multiple+Sclerosis</a><a href="https://med-mastodon.com/tags/MSchat" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#MSchat</a> <a href="https://med-mastodon.com/tags/Neurology" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#Neurology</a> <a href="https://med-mastodon.com/tags/MultipleSclerosis" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#MultipleSclerosis</a> <a href="https://med-mastodon.com/tags/ClinicalTrial" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#ClinicalTrial</a> <a href="https://med-mastodon.com/tags/botsFightMS" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#botsFightMS</a>

Benjamin Carr, Ph.D. 👨🏻‍💻🧬This shot might protect against <a href="https://hachyderm.io/tags/HIV" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#HIV</a> Promising results from an early-stage trial suggest <a href="https://hachyderm.io/tags/lenacapavir" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#lenacapavir</a> <a href="https://hachyderm.io/tags/injections" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#injections</a> might offer long-lasting protection. When it came to innovations in biotech, this year there was a clear winner: lenacapavir, was found to prevent HIV infections in 100% of the women and girls who received it in <a href="https://hachyderm.io/tags/clinicaltrial" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#clinicaltrial</a>. The drug was safe, too (it’s already approved to treat HIV). And it only needed to be injected twice a year to offer full protection. <a href="https://www.technologyreview.com/2025/03/14/1113225/annual-shot-protect-against-hiv/" rel="nofollow noopener noreferrer" translate="no" target="_blank">https://www.technologyreview.com/2025/03/14/1113225/annual-shot-protect-against-hiv/</a>

Gregory MSA Phase 2, double-blind, randomized, placebo-controlled study assessing efficacy and safety of SAR441344, a CD40L-antagonist monoclonal antibody, in participants with relapsing multiple sclerosis.<a href="https://euclinicaltrials.eu/search-for-clinical-trials/?lang=en&EUCT=2024-513527-17-00" rel="nofollow noopener noreferrer" translate="no" target="_blank">https://euclinicaltrials.eu/search-for-clinical-trials/?lang=en&EUCT=2024-513527-17-00</a><a href="https://med-mastodon.com/tags/MSchat" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#MSchat</a> <a href="https://med-mastodon.com/tags/Neurology" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#Neurology</a> <a href="https://med-mastodon.com/tags/MultipleSclerosis" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#MultipleSclerosis</a> <a href="https://med-mastodon.com/tags/ClinicalTrial" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#ClinicalTrial</a> <a href="https://med-mastodon.com/tags/botsFightMS" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#botsFightMS</a>

Gregory MSPregnancy Registry, Infants, Serum&<a href="https://med-mastodon.com/tags/x2F" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#x2F</a>;Milk Analysis (PRISMA)<a href="https://clinicaltrials.gov/study/NCT06940323?cond=Multiple+Sclerosis" rel="nofollow noopener noreferrer" translate="no" target="_blank">https://clinicaltrials.gov/study/NCT06940323?cond=Multiple+Sclerosis</a><a href="https://med-mastodon.com/tags/MSchat" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#MSchat</a> <a href="https://med-mastodon.com/tags/Neurology" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#Neurology</a> <a href="https://med-mastodon.com/tags/MultipleSclerosis" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#MultipleSclerosis</a> <a href="https://med-mastodon.com/tags/ClinicalTrial" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#ClinicalTrial</a> <a href="https://med-mastodon.com/tags/botsFightMS" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#botsFightMS</a>

Gregory MSAn open-label, multi-center, phase I&<a href="https://med-mastodon.com/tags/x2F" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#x2F</a>;II study to assess safety, disease progression, and cellular kinetics following YTB323 administration in participants with non-active Progressive Multiple Sclerosis (PMS)<a href="https://euclinicaltrials.eu/search-for-clinical-trials/?lang=en&EUCT=2024-514006-31-00" rel="nofollow noopener noreferrer" translate="no" target="_blank">https://euclinicaltrials.eu/search-for-clinical-trials/?lang=en&EUCT=2024-514006-31-00</a><a href="https://med-mastodon.com/tags/MSchat" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#MSchat</a> <a href="https://med-mastodon.com/tags/Neurology" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#Neurology</a> <a href="https://med-mastodon.com/tags/MultipleSclerosis" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#MultipleSclerosis</a> <a href="https://med-mastodon.com/tags/ClinicalTrial" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#ClinicalTrial</a> <a href="https://med-mastodon.com/tags/botsFightMS" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#botsFightMS</a>

Gregory MSUniversal Chimeric Antigen Receptor T-Cell （UCAR T-cell） Therapy Targeting CD19&<a href="https://med-mastodon.com/tags/x2F" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#x2F</a>;B Cell Maturation Antigen （CD19&<a href="https://med-mastodon.com/tags/x2F" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#x2F</a>;BCMA） in Patients With r&<a href="https://med-mastodon.com/tags/x2F" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#x2F</a>;r Neurological Autoimmune Diseases<a href="https://clinicaltrials.gov/study/NCT06939166?cond=Multiple+Sclerosis" rel="nofollow noopener noreferrer" translate="no" target="_blank">https://clinicaltrials.gov/study/NCT06939166?cond=Multiple+Sclerosis</a><a href="https://med-mastodon.com/tags/MSchat" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#MSchat</a> <a href="https://med-mastodon.com/tags/Neurology" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#Neurology</a> <a href="https://med-mastodon.com/tags/MultipleSclerosis" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#MultipleSclerosis</a> <a href="https://med-mastodon.com/tags/ClinicalTrial" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#ClinicalTrial</a> <a href="https://med-mastodon.com/tags/botsFightMS" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#botsFightMS</a>

Gregory MSSmart Monitoring Assessing Spasticity-related Health<a href="https://clinicaltrials.gov/study/NCT06937723?cond=Multiple+Sclerosis" rel="nofollow noopener noreferrer" translate="no" target="_blank">https://clinicaltrials.gov/study/NCT06937723?cond=Multiple+Sclerosis</a><a href="https://med-mastodon.com/tags/MSchat" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#MSchat</a> <a href="https://med-mastodon.com/tags/Neurology" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#Neurology</a> <a href="https://med-mastodon.com/tags/MultipleSclerosis" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#MultipleSclerosis</a> <a href="https://med-mastodon.com/tags/ClinicalTrial" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#ClinicalTrial</a> <a href="https://med-mastodon.com/tags/botsFightMS" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#botsFightMS</a>

Gregory MSPromotion of Exercise Through Physical Therapy for Multiple Sclerosis: A Pilot Study<a href="https://clinicaltrials.gov/study/NCT06933160?cond=Multiple+Sclerosis" rel="nofollow noopener noreferrer" translate="no" target="_blank">https://clinicaltrials.gov/study/NCT06933160?cond=Multiple+Sclerosis</a><a href="https://med-mastodon.com/tags/MSchat" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#MSchat</a> <a href="https://med-mastodon.com/tags/Neurology" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#Neurology</a> <a href="https://med-mastodon.com/tags/MultipleSclerosis" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#MultipleSclerosis</a> <a href="https://med-mastodon.com/tags/ClinicalTrial" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#ClinicalTrial</a> <a href="https://med-mastodon.com/tags/botsFightMS" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#botsFightMS</a>

Gregory MSA randomized, double-blind, double-dummy, parallel-group study, comparing the efficacy and safety of remibrutinib versus teriflunomide in participants with relapsing multiple sclerosis, followed by extended treatment with open-label remibrutinib<a href="https://euclinicaltrials.eu/search-for-clinical-trials/?lang=en&EUCT=2023-509372-41-00" rel="nofollow noopener noreferrer" translate="no" target="_blank">https://euclinicaltrials.eu/search-for-clinical-trials/?lang=en&EUCT=2023-509372-41-00</a><a href="https://med-mastodon.com/tags/MSchat" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#MSchat</a> <a href="https://med-mastodon.com/tags/Neurology" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#Neurology</a> <a href="https://med-mastodon.com/tags/MultipleSclerosis" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#MultipleSclerosis</a> <a href="https://med-mastodon.com/tags/ClinicalTrial" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#ClinicalTrial</a> <a href="https://med-mastodon.com/tags/botsFightMS" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#botsFightMS</a>

Recent searches

Search options

Administered by:

Server stats:

#clinicaltrial